This user has not added any information to their profile yet.
Dr. George M. Bwire is a Microbiologist and Implementation Scientist with an MSc in Medical Microbiology and Immunology from the Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania, and a PhD in Clinical and Epidemiological Virology from KU Leuven, Belgium (2024). He completed a Postdoctoral Fellowship in Global Health and Implementation Science at the Harvard T.H. Chan School of Public Health, USA (2025–2026), following a Graduate Visiting Scholarship in Global Health and Implementation Science Research (2024) and a Harvard Pre-Doctoral Fellowship in Implementation Science (2023–2024).
Dr. Bwire is a tenured Lecturer in the Department of Pharmaceutical Microbiology at the Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania. His research spans implementation science, evidence synthesis, microbiology, infectious diseases, genomic diagnostics, and health systems strengthening, with a particular focus on translating research evidence into policy and practice to improve healthcare delivery in low- and middle-income countries. He has over 10 years of research experience and has contributed to multidisciplinary projects supported by the National Institutes of Health (NIH), Wellcome Trust, UNICEF, Sida, and other international partners.
Dr. Bwire has published more than 50 PubMed-indexed peer-reviewed scientific articles and has extensive experience conducting systematic reviews, meta-analyses, umbrella reviews, and implementation research. His current work focuses on developing and evaluating sustainable implementation strategies for decentralized genomic diagnostics, HIV drug resistance surveillance, and other innovations that strengthen laboratory systems and improve equitable access to evidence-based healthcare. He actively collaborates with national and international universities, governments, and global health organizations to advance research, capacity building, and evidence-informed policymaking.
My research aims to bridge the gap between scientific discovery and routine healthcare by integrating implementation science, evidence synthesis, and health systems research. I am particularly interested in developing, evaluating, and scaling evidence-based interventions that improve healthcare quality, accessibility, and equity in low- and middle-income countries.
My current research focuses on strengthening health systems through the implementation of innovative diagnostic technologies, particularly decentralized and near point-of-care genomic diagnostics for HIV drug resistance and other infectious diseases. I apply mixed-methods implementation research, systems thinking, and stakeholder co-design to identify barriers and facilitators to implementation and to develop sustainable strategies for integrating innovations into routine healthcare.
In parallel, I conduct systematic reviews, meta-analyses, umbrella reviews, and secondary analyses to generate high-quality evidence that informs clinical guidelines, health policy, and implementation strategies. Through multidisciplinary collaborations with academic institutions, governments, and international organizations, I strive to translate research findings into policies and practices that improve population health and strengthen resilient health systems.
Implementing Research on Provision of Antiretroviral Therapy and Pre-Exposure Prophylaxis (PrEP) Services through Community Pharmacies in Tanzania (2025–2026)| Principal Investigator | National Institutes of Health (NIH), Fogarty International Center, USA.
Feasibility of Implementing Vaccination Programs Through Community Pharmacies in Tanzania (2025–2026)| Principal Investigator | University of Rwanda – East African Community Regional Centre of Excellence for Vaccines, Immunization and Health Supply Chain Management.
Exploring the Role of Doxycycline in Improving Surgical Outcomes among Women with Stage III Breast Cancer in Tanzania (2025–Ongoing)| Co-Principal Investigator | Cures Within Reach.
Prevention of HIV Drug Resistance in Dar es Salaam, Tanzania (2023–2024)| Principal Investigator | National Institutes of Health (NIH), Fogarty International Center, USA.
Designing Interventions to Prevent HIV Drug Resistance (2023–2028)| Investigator | VLIR-UOS TEAM Programme.
Promoting Access and Rational Use of Antibiotics in Children: An Implementation Research Project (2020–2022)| Principal Investigator | Wellcome Trust and UNICEF.
Surveillance of Antimalarial Resistance in Tanzania (2019–2020)| Principal Investigator | Wellcome Sanger Institute, Research Genome Ltd (UK), and Sida, Sweden.
Bwire, G.M., Itaeli, A., Killewo, J. and Sudfeld, C.R. (2026). Acceptability and implementation considerations for community pharmacy-based delivery of pre-exposure prophylaxis and antiretroviral therapy in Dar es Salaam: A sequential explanatory mixed-methods design. BMC Public Health. https://pubmed.ncbi.nlm.nih.gov/42204514/
Aiko, B.G., Guariguata, L., Myemba, D.T., Bwire, G.M., Nyondo, G.G., Sangeda, R.Z., Killewo, J., Vandaele, N. and Decouttere, C. (2026). Simulation modeling for the design and evaluation of HIV drug resistance interventions: A systematic review of literature. BMC Public Health. https://pubmed.ncbi.nlm.nih.gov/42135718/
Thadeo, M.H. and Bwire, G.M. (2026). Timeliness of switching to second-line antiretroviral therapy following virologic failure in Dar es Salaam, Tanzania. BMC Research Notes. https://pubmed.ncbi.nlm.nih.gov/42104392/
Marealle, A.I., Nyondo, G.G., Manguzu, M.A., Munishi, C.G. and Bwire, G.M. (2026). Hepatitis B non-vaccination rate and associated factors among healthcare workers in low- and middle-income countries: A systematic review and meta-analysis. Reviews in Medical Virology. https://pubmed.ncbi.nlm.nih.gov/42170843/
Joseph, P.E., Itaeli, A.M., Amour, M. and Bwire, G.M. (2026). Effects of transition from paediatric to adult HIV care on virological outcomes in sub-Saharan Africa: A systematic review and meta-analysis. HIV Medicine. https://doi.org/10.1111/hiv.70221
Myemba, D.T., Bwire, G.M., Aiko, B.G., Guariguata, L., Sunguya, B.F., Vandaele, N. and Decouttere, C. (2026). A systems approach to understanding mechanisms underlying immunisation barriers: A participatory design study in Tanzania. BMJ Global Health. https://doi.org/10.1136/bmjgh-2025-019686
Bwire, G.M., Nyondo, G.G., Mbilinyi, T., Magati, R.B., Mganga, M. and Nshau, A.B. (2026). Leveraging community drug outlets for vaccination delivery in Tanzania: A qualitative study to inform future implementation. International Journal of Health Planning and Management. https://doi.org/10.1002/hpm.70065
Njiro, B.J. and Bwire, G.M. (2026). Surveillance of HIV-1 drug resistance in Tanzania across the pre- and post-dolutegravir eras: A systematic review and meta-analysis. Journal of Infection and Public Health.
Shayo, V., Bwire, G.M., Matee, M.I.N. et al. (2025). Post-COVID-19 era sero-surveillance of anti-measles IgM and IgG antibodies among asymptomatic Tanzanian children aged 3–15 years. Immunologic Research, 73(1), Article 87. https://doi.org/10.1007/s12026-025-09645-2
Bwire, G.M., Magati, R.B., Ntissi, H.H. et al. (2025). Synthesizing evidence to guide the design and implementation of effective strategies for discontinuing postoperative antibiotic prophylaxis in surgical settings: An umbrella review post-WHO 2018 recommendations. Systematic Reviews, 14, Article 7. https://doi.org/10.1186/s13643-024-02750-7
